Management of alloimmunized, refractory patients in need of platelet transfusions

Vox Sang. 1997;73(3):191-8. doi: 10.1046/j.1423-0410.1997.73301911.x.

Authors

C P Engelfriet¹, H W Reesink, R H Aster, A Brand, B Tomson, F H Claas, M Contreras, C Navarrete, J Jørgensen, M F Murphy, R Curtis, A H Waters, S Panzer, M Kurz, P Höcker, W R Mayr, C A Schiffer

Affiliation

¹ Central Blood Laboratories, Netherlands Red Cross, Blood Transfusion Service, CX Amsterdam, The Netherlands.

PMID: 9358625
DOI: 10.1046/j.1423-0410.1997.73301911.x

No abstract available

Publication types

Clinical Trial
Randomized Controlled Trial

MeSH terms

Histocompatibility Antigens Class I / immunology*
Humans
Isoantibodies / blood*
Platelet Transfusion*

Substances

Histocompatibility Antigens Class I
Isoantibodies